Send Message
U-CHOICE GROUP 86-371-61299996
Docetaxel USP38 Taxane Drugs For Treatment Of Breast , CAS 114977-28-5

Docetaxel USP38 Taxane Drugs For Treatment Of Breast , CAS 114977-28-5

  • High Light

    taxane chemotherapy for breast cancer

    ,

    taxane chemotherapy drugs

  • Color
    White Or Off White
  • Appearance
    Crystal Powder
  • Standard
    USP38
  • M.F
    C43H53NO14
  • CAS No.
    14977-28-5
  • UN Number
    1544
  • HS Code
    2932999099
  • Other Name
    AP-5
  • Place of Origin
    Henan Province, China
  • Brand Name
    U-CHOICE
  • Certification
    ISO 9001 : 2008
  • Model Number
    USP38
  • Minimum Order Quantity
    500g
  • Price
    Negotiate
  • Packaging Details
    as demand
  • Delivery Time
    3-5 working days
  • Payment Terms
    T/T,
  • Supply Ability
    500 Kgs Per Month

Docetaxel USP38 Taxane Drugs For Treatment Of Breast , CAS 114977-28-5

Docetaxel USP38 CAS No. 114977-28-5 Taxane Drugs White or off white crystalline powder

 

Technical Information

 

Technical Item Technical Data

Density

1.4±0.1 g/cm3

Boiling Point

900.5±65.0 ℃ at 760 mmHg

Molecular Formula

C43H53NO14

Molecular  Weight

807.879

Flash Point

498.4±34.3 

Exact Mass

807.346619

PSA

224.45000

Log P

6.55

Vapour Pressure

0.0± 0.3 mmHg at 25℃

Refractive Index

1.618

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Docetaxel (trade name Taxotere) is a clinically well established anti-mitotic chemotherapy medication (that is, it interferes with cell division).

 

Function:
Docetaxel is used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.

Docetaxel has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. An European approval docetaxel for use in hormone-refractory prostate cancer. Docetaxel is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule.

1.It is a clinically well established anti-mitotic chemotherapy medication (that is, it interferes with cell division).
2.It is used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.
3.It has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline based chemotherapy and failed to stop cancer progression or relapsed. An European approval docetaxel for use in hormone-refractory prostate cancer.
4.It is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule.

 

Application:
Docetaxel intermediate is a crucial intermediate for Docitaxel, two of the best anti-cancer drugs ever invented. By extracting the pre-cursor, docetaxel intermediate in large quantites from the Taxus baccata leaf, many subsequent semi-syntheses can be carried out.
The esterification of docetaxel intermediate also causes an enhancement in the kinetics, and therefore the pharmacological profile of these important chemo-therapeutic agents.